Literature DB >> 11092576

A quantitative evaluation of the permeability of the blood brain barrier of portacaval shunted rats.

B Alexander1, X Li, I S Benjamin, M B Segal, R Sherwood, J E Preston.   

Abstract

The integrity of the blood-brain barrier (BBB) was measured in male Sprague Dawley rats subjected to 16 weeks of portacaval shunting (PCS), the optimal time required for the cerebral changes to develop, by using an in situ brain perfusion technique. The penetration of a vascular space marker 14C mannitol, and labelled amino acids 3H-phenylalanine or 3H-glutamate were measured in brain and cerebrospinal fluid (CSF) using an in situ brain perfusion technique, over 2 or 20 minutes. The patency of the surgical shunt was confirmed by measurement of significantly increased plasma ammonia (131.5 +/- 14.8 micromol x l(-1)) and AST (159.5 +/- 19.9 IU x l(-1)) concentrations compared to controls 39.9 +/- 3.7*, and 82.5 +/- 6.6* respectively. Brain and CSF 14C-mannitol space (ml x 100g(-1)), was not increased by PCS where brain space was 1.31 +/- 0.27 mL x 100g(-1) compared to control 1.19 +/- 0.49 mL x 100g(-1), and CSF was 0.14 +/- 0.06 mL x 100g(-1) compared to control 0.15 +/- 0.05 (PCS n=10, control n=8). The uptake for 3H-glutamate, which is required for cerebral ammonia detoxification, was also unchanged in both brain and CSF. However, brain uptake of 3H-phenylalanine was significantly reduced from 871 +/- 80 microL x min(-1) x g(-1) to 356 +/- 154* microl x min(-1) x g(-1) (n=4), although there was no change in CSF uptake. These data suggest that there is no generalized breakdown of the blood-brain or blood-CSF barriers during PCS as assessed by mannitol penetration. The reduction in phenylalanine uptake into the brain may help stabilize high cerebral aromatic amino acid levels. *P<0.05, Two-tailed, Student's unpaired t-test.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11092576     DOI: 10.1007/BF02679976

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.655


  32 in total

1.  An investigation of the relationship between the liver and brain using an isolated perfused rat brain preparation.

Authors:  B Alexander; M Aslam; I S Benjamin
Journal:  J Pharmacol Toxicol Methods       Date:  1999-09       Impact factor: 1.950

2.  Permeability of the blood-brain barrier after portocaval anastomosis in the rat.

Authors:  G S Sarna; M W Bradbury; J Cavanagh
Journal:  Brain Res       Date:  1977-12-23       Impact factor: 3.252

3.  Amino acids in hepatic coma.

Authors:  J E Fischer
Journal:  Dig Dis Sci       Date:  1982-02       Impact factor: 3.199

4.  Elevated brain 5-hydroxytryptophol levels in experimental portal-systemic encephalopathy.

Authors:  P B Bergqvist; M Some; G Apelqvist; A Helander; F Bengtsson
Journal:  Pharmacol Toxicol       Date:  1997-04

5.  Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat.

Authors:  K Ohno; K D Pettigrew; S I Rapoport
Journal:  Am J Physiol       Date:  1978-09

Review 6.  Hepatic encephalopathy and ascites.

Authors:  R Jalan; P C Hayes
Journal:  Lancet       Date:  1997-11-01       Impact factor: 79.321

7.  The dependence of hepatic function upon sufficient oxygen supply during prolonged isolated rat liver perfusion.

Authors:  B Alexander; M Aslam; I S Benjamin
Journal:  J Pharmacol Toxicol Methods       Date:  1998-06       Impact factor: 1.950

8.  Brain distribution spaces of mannitol-3H, inulin-14C, and dextran-14C in the rat.

Authors:  W B Sisson; W H Oldendorf
Journal:  Am J Physiol       Date:  1971-07

9.  Differentiation between the effects of unprocessed portal blood and reduced liver function on brain indole amine metabolism in the portacaval shunted rat.

Authors:  B Alexander; M Aslam; A Nobin; I S Benjamin
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

10.  Portacaval transposition in the rat: definition of a valuable model for hepatic research.

Authors:  I S Benjamin; C J Ryan; G H Engelbrecht; J A Campbell; R van Hoorn-Hickman; L H Blumgart
Journal:  Hepatology       Date:  1984 Jul-Aug       Impact factor: 17.425

View more
  7 in total

Review 1.  CNS drug delivery: opioid peptides and the blood-brain barrier.

Authors:  Ken A Witt; Thomas P Davis
Journal:  AAPS J       Date:  2006-02-24       Impact factor: 4.009

Review 2.  Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation.

Authors:  Dominic R Aldridge; Edward J Tranah; Debbie L Shawcross
Journal:  J Clin Exp Hepatol       Date:  2014-06-30

3.  Hyperammonaemia reduces intracellular 22Na (sodium) ion and extracellular 86Rb ion concentrations in the blood-brain barrier of the rat.

Authors:  Barry Alexander; Kevin A Smart; Malcolm B Segal; Jane E Preston
Journal:  Metab Brain Dis       Date:  2005-03       Impact factor: 3.584

4.  Mitochondrial Changes in Rat Brain Endothelial Cells Associated with Hepatic Encephalopathy: Relation to the Blood-Brain Barrier Dysfunction.

Authors:  Krzysztof Milewski; Karolina Orzeł-Gajowik; Magdalena Zielińska
Journal:  Neurochem Res       Date:  2022-08-02       Impact factor: 4.414

5.  Altered blood-brain barrier permeability in rats with prehepatic portal hypertension turns to normal when portal pressure is lowered.

Authors:  Francisco Eizayaga; Camila Scorticati; Juan-P Prestifilippo; Salvador Romay; Maria-A Fernandez; Jose-L Castro; Abraham Lemberg; Juan-C Perazzo
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

Review 6.  Alterations of blood brain barrier function in hyperammonemia: an overview.

Authors:  Marta Skowrońska; Jan Albrecht
Journal:  Neurotox Res       Date:  2011-08-27       Impact factor: 3.911

7.  Alterations of blood-brain barrier and associated factors in acute liver failure.

Authors:  Wei Cui; Cui-Ming Sun; Pei Liu
Journal:  Gastroenterol Res Pract       Date:  2013-05-26       Impact factor: 2.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.